BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bartlett EK, Roses RE, Kelz RR, Drebin JA, Fraker DL, Karakousis GC. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery. 2014;156:298-304. [PMID: 24947651 DOI: 10.1016/j.surg.2014.03.022] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Cai Y, Chen S, Chen X, Chen W, Wang P, Zhu G, Jin J, M.a B. Association of Sarcopenia and Low Nutritional Status with Unplanned Hospital Readmission after Radical Gastrectomy in Patients with Gastric Cancer: A Case-Control Study. Journal of Healthcare Engineering 2022;2022:1-9. [DOI: 10.1155/2022/7246848] [Reference Citation Analysis]
2 Yang J, Zhang X, Li K, Zhou Y, Hu Y, Chen X, Liang S, Jiang L. Effects of EN combined with PN enriched with n-3 polyunsaturated fatty acids on immune related indicators and early rehabilitation of patients with gastric cancer: A randomized controlled trial. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.03.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study. World J Gastroenterol 2022;28:381-98. [PMID: 35110956 DOI: 10.3748/wjg.v28.i3.381] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Castro JSL, Pelosof AG, Andrade-Cabral JGG, Seraphim AM, Taglieri E, Coimbra FJF, Zitron C. ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS. Arq Bras Cir Dig 2022;34:e1616. [PMID: 35019128 DOI: 10.1590/0102-672020210002e1616] [Reference Citation Analysis]
5 Latrille A, Bouvier AM, Jooste V, Bengrine Lefevre L, Quipourt V, Moreno Lopez N, Facy O. Surgical treatment of digestive cancer in a well-defined elderly population. Clin Res Hepatol Gastroenterol 2021;:101857. [PMID: 34963649 DOI: 10.1016/j.clinre.2021.101857] [Reference Citation Analysis]
6 van Winsen M, McSorley ST, McLeod R, MacDonald A, Forshaw MJ, Shaw M, Puxty K. Postoperative C-reactive protein concentrations to predict infective complications following gastrectomy for cancer. J Surg Oncol 2021. [PMID: 34350587 DOI: 10.1002/jso.26613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Jeong JR, Choi JW, Ryu SY, Choe YR. Relationship between frailty and mortality after gastrectomy in older patients with gastric cancer. J Geriatr Oncol 2021:S1879-4068(21)00158-2. [PMID: 34272203 DOI: 10.1016/j.jgo.2021.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rebecchi F, Arolfo S, Ugliono E, Morino M, Asti E, Bonavina L, Borghi F, Coratti A, Cossu A, De Manzoni G, De Pascale S, Ferrari GC, Fumagalli Romario U, Giacopuzzi S, Gualtierotti M, Guglielmetti M, Merigliano S, Pallabazzer G, Parise P, Peri A, Pietrabissa A, Rosati R, Santi S, Tribuzi A, Valmasoni M, Viganò J, Weindelmayer J. Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot. Dis Esophagus 2021;34:doaa124. [PMID: 33245104 DOI: 10.1093/dote/doaa124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shannon AB, Straker RJ 3rd, Fraker DL, Roses RE, Miura JT, Karakousis GC. Ninety-day mortality after total gastrectomy for gastric cancer. Surgery 2021;170:603-9. [PMID: 33789812 DOI: 10.1016/j.surg.2021.02.010] [Reference Citation Analysis]
10 Park JH, Lee HJ, Oh SY, Park SH, Berlth F, Son YG, Kim TH, Huh YJ, Yang JY, Lee KG, Suh YS, Kong SH, Yang HK. Prediction of Postoperative Mortality in Patients with Organ Failure After Gastric Cancer Surgery. World J Surg 2020;44:1569-77. [PMID: 31993720 DOI: 10.1007/s00268-020-05382-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Iwatsuki M, Yamamoto H, Miyata H, Kakeji Y, Yoshida K, Konno H, Seto Y, Baba H. Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system. Gastric Cancer 2021;24:526-34. [PMID: 33037492 DOI: 10.1007/s10120-020-01127-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kulshrestha S, Bunn C, Gonzalez R, Afshar M, Luchette FA, Baker MS. Unhealthy alcohol and drug use is associated with an increased length of stay and hospital cost in patients undergoing major upper gastrointestinal and pancreatic oncologic resections. Surgery 2021;169:636-43. [PMID: 32951904 DOI: 10.1016/j.surg.2020.07.059] [Reference Citation Analysis]
13 Polkowski WP, Sędłak K, Rawicz-Pruszyński K. Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable. Cancer Manag Res 2020;12:6467-76. [PMID: 32801886 DOI: 10.2147/CMAR.S260842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bausys A, Luksta M, Kuliavas J, Anglickiene G, Maneikiene V, Gedvilaite L, Celutkiene J, Jamontaite I, Cirtautas A, Lenickiene S, Vaitkeviciute D, Gaveliene E, Klimaviciute G, Bausys R, Strupas K. Personalized trimodal prehabilitation for gastrectomy. Medicine (Baltimore) 2020;99:e20687. [PMID: 32629639 DOI: 10.1097/MD.0000000000020687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rodrigues V, Landi F, Castro S, Mast R, Rodríguez N, Gantxegi A, Pradell J, López-Cano M, Armengol M. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population. J Gastrointest Surg 2021;25:1388-403. [PMID: 32661833 DOI: 10.1007/s11605-020-04716-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sivakumar J, Alnimri F, Johnson MA, Ward S, Chong L, Hii MW. Health economic analysis of curative-intent gastrectomy for gastric carcinoma and the costs related to post-operative complications. ANZ J Surg 2021;91:E1-6. [PMID: 32483869 DOI: 10.1111/ans.16014] [Reference Citation Analysis]
17 Tuech JJ, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K, Pocard M, Schwarz L. Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic. J Visc Surg. 2020;157:S7-S12. [PMID: 32249098 DOI: 10.1016/j.jviscsurg.2020.03.008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 39.5] [Reference Citation Analysis]
18 Tuech JJ, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K, Pocard M, Schwarz L. [Strategy for the practice of digestive and oncologic surgery in COVID-19 epidemic situation]. J Chir Visc 2020;157:S6-S12. [PMID: 32834885 DOI: 10.1016/j.jchirv.2020.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Güner A. The efficacy of clinical pathway in gastric cancer surgery. Turk J Surg 2020;36:39-47. [PMID: 32637874 DOI: 10.5578/turkjsurg.4547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ze-Long Y, Guo-Hui M, Lin Z, Wei-Hong Y, Ke-Cheng Z, Yan-Wen J. Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States. Am J Clin Oncol. 2019;42:581-587. [PMID: 31157623 DOI: 10.1097/coc.0000000000000558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ganschow P, Hofmann L, Stintzing S, Heinemann V, Angele M, Werner J, Schulz C. Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment. J Gastrointest Surg 2021;25:58-66. [PMID: 32040809 DOI: 10.1007/s11605-019-04511-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Li SS, Udelsman BV, Parikh A, Klempner SJ, Clark JW, Roeland EJ, Wo JY, Hong TS, Mullen JT. Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer. J Am Coll Surg 2020;230:912-24. [PMID: 32035978 DOI: 10.1016/j.jamcollsurg.2019.12.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
23 Eichelmann AK, Saidi M, Lindner K, Lenschow C, Palmes D, Pascher A, Hummel R. Impact of preoperative risk factors on outcome after gastrectomy. World J Surg Oncol 2020;18:17. [PMID: 31980026 DOI: 10.1186/s12957-020-1790-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Norero E, Quezada JL, Cerda J, Ceroni M, Martinez C, Mejía R, Muñoz R, Araos F, González P, Díaz A. RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS. Arq Bras Cir Dig 2019;32:e1473. [PMID: 31859926 DOI: 10.1590/0102-672020190001e1473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Coimbra FJF, de Jesus VHF, Franco CP, Calsavara VF, Ribeiro HSC, Diniz AL, de Godoy AL, de Farias IC, Riechelmann RP, Begnami MDFS, da Costa WL. Predicting overall and major postoperative morbidity in gastric cancer patients. J Surg Oncol. 2019;120:1371-1378. [PMID: 31696512 DOI: 10.1002/jso.25743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
26 Levy J, Gupta V, Amirazodi E, Allen-ayodabo C, Jivraj N, Jeong Y, Davis LE, Mahar AL, De Mestral C, Saarela O, Coburn N; on behalf of the PRESTO Group. Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO). Gastric Cancer 2020;23:391-402. [DOI: 10.1007/s10120-019-01015-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
27 Wu Z, Cheng H, Shan F, Ying X, Miao R, Dong J, Sun Y, Xu A, Zhou Y, Wang Y, Chen L, Xue Y, Cao H, Hua Y, Xu Z, Zheng M, Yan M, Huang C, Suo J, Liang H, Fan L, Hu J, Hu X, Li G, Yu P, Li G, Shi Y, Luo H, Li Y, Xie M, Liu T, Zhang Z, Shi T, Li Z, Ji J. In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients. Front Oncol 2019;9:846. [PMID: 31632900 DOI: 10.3389/fonc.2019.00846] [Reference Citation Analysis]
28 Kanda M. Preoperative predictors of postoperative complications after gastric cancer resection. Surg Today 2020;50:3-11. [PMID: 31535226 DOI: 10.1007/s00595-019-01877-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Leiting JL, Grotz TE. Advancements and challenges in treating advanced gastric cancer in the West. World J Gastrointest Oncol 2019; 11(9): 652-664 [PMID: 31558971 DOI: 10.4251/wjgo.v11.i9.652] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
30 Beetham H, Chen A, Telford BJ, Single A, Jarman KE, Lackovic K, Luxenburger A, Guilford P. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Sci Rep 2019;9:12511. [PMID: 31467357 DOI: 10.1038/s41598-019-48929-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Yuan P, Wu Z, Li Z, Bu Z, Wu A, Wu X, Zhang L, Shi J, Ji J. Impact of postoperative major complications on long-term survival after radical resection of gastric cancer. BMC Cancer 2019;19:833. [PMID: 31443699 DOI: 10.1186/s12885-019-6024-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
32 Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H. Short-Term Outcomes of Laparoscopic and Open Total Gastrectomy for Gastric Cancer: A Nationwide Retrospective Cohort Analysis. Ann Surg Oncol 2020;27:518-26. [PMID: 31407172 DOI: 10.1245/s10434-019-07688-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
33 Xu Y, Wang Y, Xi C, Ye N, Xu X. Is it safe to perform gastrectomy in gastric cancer patients aged 80 or older?: A meta-analysis and systematic review. Medicine (Baltimore) 2019;98:e16092. [PMID: 31192972 DOI: 10.1097/MD.0000000000016092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
34 Wu J, Ho T, Tien Y. Correlation Between the Increased Hospital Volume and Decreased Overall Perioperative Mortality in One Universal Health Care System. World J Surg 2019;43:2194-202. [DOI: 10.1007/s00268-019-05025-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Wu C, Wang N, Zhou H, Wang T, Mao Q, Zhang X, Zhao D. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer. J Gastrointest Surg 2020;24:1278-89. [PMID: 31140064 DOI: 10.1007/s11605-019-04257-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Li SS, Costantino CL, Mullen JT. Morbidity and Mortality of Total Gastrectomy: a Comprehensive Analysis of 90-Day Outcomes. J Gastrointest Surg. 2019;23:1340-1348. [PMID: 31062268 DOI: 10.1007/s11605-019-04228-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Ju T, Rivas L, Kurland K, Chen S, Sparks A, Lin PP, Vaziri K. National trends in total vs subtotal gastrectomy for middle and distal third gastric cancer. Am J Surg. 2020;219:691-695. [PMID: 31030990 DOI: 10.1016/j.amjsurg.2019.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 van Putten M, Lemmens VEPP, van Laarhoven HWM, Pruijt HFM, Nieuwenhuijzen GAP, Verhoeven RHA. Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival. Eur J Surg Oncol 2019;45:1926-33. [PMID: 30982656 DOI: 10.1016/j.ejso.2019.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Azari FS, Roses RE. Management of Early Stage Gastric and Gastroesophageal Junction Malignancies. Surg Clin North Am. 2019;99:439-456. [PMID: 31047034 DOI: 10.1016/j.suc.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Holmstrom AL, Aadam AA, Hungness ES. Submucosal endoscopy. Techniques in Gastrointestinal Endoscopy 2018;20:211-7. [DOI: 10.1016/j.tgie.2018.09.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 13.3] [Reference Citation Analysis]
42 Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, Sandroussi C. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol 2018;16:136. [PMID: 29986713 DOI: 10.1186/s12957-018-1422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
43 Byrne BE, Rogers CA, Blazeby JM. The end of bursectomy for gastric cancer? Lancet Gastroenterol Hepatol 2018;3:446-7. [PMID: 29709559 DOI: 10.1016/S2468-1253(18)30135-3] [Reference Citation Analysis]
44 Li Z, Bai B, Zhao Y, Yu D, Lian B, Liu Y, Zhao Q. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study. Int J Surg 2018;54:62-9. [PMID: 29698790 DOI: 10.1016/j.ijsu.2018.04.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
45 Claassen YHM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. Eur J Surg Oncol. 2018;44:613-619. [PMID: 29503129 DOI: 10.1016/j.ejso.2018.02.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
46 Rosemurgy A, Whitaker J, Luberice K, Rodriguez C, Downs D, Ross S. A Cost-Benefit Analysis of Reducing Surgical Site Infections. The American Surgeon 2018;84:254-61. [DOI: 10.1177/000313481808400234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ammori JB, Navale S, Schiltz N, Koroukian SM. Predictors of 30-day readmissions after gastrectomy for malignancy. J Surg Res 2018;224:176-84. [PMID: 29506837 DOI: 10.1016/j.jss.2017.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Hamilton TD, Mahar AL, Haas B, Beyfuss K, Law CHL, Karanicolas PJ, Coburn NG, Hallet J. The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis. Gastric Cancer 2018;21:710-9. [DOI: 10.1007/s10120-017-0786-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
49 Sun F, Ge X, Liu Z, Du S, Ai S, Guan W. Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World J Surg Oncol 2017;15:191. [PMID: 29065877 DOI: 10.1186/s12957-017-1258-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
50 Ciesielski M, Kruszewski WJ, Walczak J, Szajewski M, Szefel J, Wydra J, Buczek T, Czerepko M. Analysis of postoperative morbidity and mortality following surgery for gastric cancer. Surgeon volume as the most significant prognostic factor. Prz Gastroenterol 2017;12:215-21. [PMID: 29123584 DOI: 10.5114/pg.2017.70475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Arsoniadis EG, Marmor S, Diep GK, Hui JYC, Jensen EH, Tuttle TM. Survival Rates for Patients with Resected Gastric Adenocarcinoma Finally have Increased in the United States. Ann Surg Oncol 2017;24:3361-7. [DOI: 10.1245/s10434-017-5992-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
52 Kikuchi H, Miyata H, Konno H, Kamiya K, Tomotaki A, Gotoh M, Wakabayashi G, Mori M. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer 2017;20:987-97. [PMID: 28285387 DOI: 10.1007/s10120-017-0706-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
53 Norero E, Vega EA, Diaz C, Cavada G, Ceroni M, Martínez C, Briceño E, Araos F, Gonzalez P, Baez S, Vinuela E, Caracci M, Diaz A. Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre. Eur J Surg Oncol 2017;43:1330-6. [PMID: 28359594 DOI: 10.1016/j.ejso.2017.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
54 Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A Jr, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol 2017;24:2291-301. [PMID: 27770339 DOI: 10.1245/s10434-016-5601-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
55 Tanaka Y, Kanda M, Tanaka C, Kobayashi D, Mizuno A, Iwata N, Hayashi M, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y. Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2–4 gastric cancer. Gastric Cancer 2017;20:736-43. [DOI: 10.1007/s10120-016-0657-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
56 Zhou J, Hiki N, Mine S, Kumagai K, Ida S, Jiang X, Nunobe S, Ohashi M, Sano T, Yamaguchi T. Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery. Ann Surg Oncol 2017;24:510-7. [PMID: 27638673 DOI: 10.1245/s10434-016-5548-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
57 Teng A, Bellini G, Pettke E, Passeri M, Lee DY, Rose K, Bilchik AJ, Attiyeh F. Outcomes of octogenarians undergoing gastrectomy performed for malignancy. J Surg Res 2017;207:1-6. [PMID: 27979463 DOI: 10.1016/j.jss.2016.08.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
58 Takeuchi M, Ishii K, Seki H, Yasui N, Sakata M, Shimada A, Matsumoto H. Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study. BMC Surg 2016;16:54. [PMID: 27494994 DOI: 10.1186/s12893-016-0168-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
59 Chen FF, Zhang FY, Zhou XY, Shen X, Yu Z, Zhuang CL. Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study. Langenbecks Arch Surg 2016;401:813-22. [PMID: 27485549 DOI: 10.1007/s00423-016-1490-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
60 Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT. The impact of the extent of surgical resection on survival of gastric cancer patients. Onco Targets Ther. 2016;9:4687-4694. [PMID: 27555787 DOI: 10.2147/ott.s97699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Greenleaf EK, Kulaylat AN, Hollenbeak CS, Almhanna K, Wong J. Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer. Ann Surg Oncol 2016;23:4203-13. [PMID: 27459982 DOI: 10.1245/s10434-016-5464-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
62 Nakagawa M, Choi YY, An JY, Seo SH, Shin HB, Bang HJ, Li S, Kim HI, Cheong JH, Hyung WJ, Noh SH. When Eastern Surgeons Meet Western Patients: A Pilot Study of Gastrectomy with Lymphadenectomy in Caucasian Patients at a Single Korean Institute. Yonsei Med J 2016;57:1294-7. [PMID: 27401666 DOI: 10.3349/ymj.2016.57.5.1294] [Reference Citation Analysis]
63 Fuentes E, Ahmad R, Hong TS, Clark JW, Kwak EL, Rattner DW, Mullen JT. The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality. J Surg Oncol 2016;113:560-4. [PMID: 26792144 DOI: 10.1002/jso.24179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
64 Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56:1177-85. [PMID: 26256958 DOI: 10.3349/ymj.2015.56.5.1177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
65 Chen FF, Huang DD, Lu JX, Zhou CJ, Zhuang CL, Wang SL, Shen X, Yu Z, Chen XL. Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes. J Gastrointest Surg 2016;20:521-30. [PMID: 26691150 DOI: 10.1007/s11605-015-3059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Greenleaf EK, Hollenbeak CS, Wong J. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database. Surgery. 2016;159:1099-1112. [PMID: 26704785 DOI: 10.1016/j.surg.2015.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
67 Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan. World J Surg 2016;40:1165-71. [DOI: 10.1007/s00268-015-3362-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
68 Newton AD, Datta J, Loaiza-Bonilla A, Karakousis GC, Roses RE. Neoadjuvant therapy for gastric cancer: current evidence and future directions. J Gastrointest Oncol. 2015;6:534-543. [PMID: 26487948 DOI: 10.3978/j.issn.2078-6891.2015.047] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
69 Pujara D, Mansfield P, Ajani J, Blum M, Elimova E, Chiang YJ, Das P, Badgwell B. Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy. J Surg Oncol 2015;112:883-7. [PMID: 26482869 DOI: 10.1002/jso.24077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
70 Fuentes E, Ahmad R, Hong TS, Clark JW, Kwak EL, Rattner DW, Mullen JT. Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach. J Gastrointest Surg 2016;20:172-9; discussion 179. [PMID: 26394879 DOI: 10.1007/s11605-015-2954-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
71 Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, Ramón JM, García-Albéniz X, Grande L, Pera M. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol 2016;42:132-9. [PMID: 26385054 DOI: 10.1016/j.ejso.2015.08.163] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
72 Tegels JJ, van Vugt JL, Reisinger KW, Hulsewé KW, Hoofwijk AG, Derikx JP, Stoot JH. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 2015;112:403-7. [PMID: 26331988 DOI: 10.1002/jso.24015] [Cited by in Crossref: 67] [Cited by in F6Publishing: 85] [Article Influence: 9.6] [Reference Citation Analysis]
73 Lowenfeld L, Datta J, Lewis RS, Mcmillan MT, Mamtani R, Damjanov N, Chandrasekhara V, Karakousis GC, Drebin JA, Fraker DL, Roses RE. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. Ann Surg Oncol 2015;22:863-72. [DOI: 10.1245/s10434-015-4677-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
74 Peters MG, Bartlett EK, Roses RE, Kelz RR, Fraker DL, Karakousis GC. Age-Related Morbidity and Mortality with Cytoreductive Surgery. Ann Surg Oncol 2015;22 Suppl 3:S898-904. [PMID: 26014156 DOI: 10.1245/s10434-015-4624-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
75 Kim S, Yoo YS, Kim JH, Min YD. Analysis of patient-dropouts from the critical pathways for gastric cancer. Ann Surg Treat Res 2015;88:311-7. [PMID: 26029676 DOI: 10.4174/astr.2015.88.6.311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Zhuang CL, Wang SL, Huang DD, Pang WY, Lou N, Chen BC, Chen XL, Yu Z, Shen X. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PLoS One 2015;10:e0125572. [PMID: 25915547 DOI: 10.1371/journal.pone.0125572] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
77 Tegels JJ, Hulsewé KW, Sosef MN, Stoot JH. Morbidity and mortality after total gastrectomy for gastric malignancy: do not forget about geriatric frailty and nutrition. Surgery 2015;157:406-7. [PMID: 25616952 DOI: 10.1016/j.surg.2014.10.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Tran TB, Worhunsky DJ, Squires MH, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber S, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Norton JA, Poultsides GA. Outcomes of Gastric Cancer Resection in Octogenarians: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol 2015;22:4371-9. [DOI: 10.1245/s10434-015-4530-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
79 Zhou J, Yu P, Shi Y, Tang B, Hao Y, Zhao Y, Qian F. Evaluation of Clavien-Dindo classification in patients undergoing total gastrectomy for gastric cancer. Med Oncol 2015;32:120. [PMID: 25788033 DOI: 10.1007/s12032-015-0573-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
80 Matsumoto S, Takayama T, Wakatsuki K, Tanaka T, Migita K, Ito M, Nakade H, Kunishige T, Nakajima Y. Preoperative Cardiac Risk Assessment and Surgical Outcomes of Patients with Gastric Cancer. Ann Surg Oncol 2016;23:222-9. [DOI: 10.1245/s10434-015-4464-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
81 Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, Coit DG, Strong VE. Morbidity after Total Gastrectomy: Analysis of 238 Patients. J Am Coll Surg 2015;220:863-871.e2. [PMID: 25842172 DOI: 10.1016/j.jamcollsurg.2015.01.058] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
82 Schwarz RE. Current status of management of malignant disease: current management of gastric cancer. J Gastrointest Surg. 2015;19:782-788. [PMID: 25591828 DOI: 10.1007/s11605-014-2707-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
83 da Costa WL Jr, Coimbra FJ, Ribeiro HS, Diniz AL, de Godoy AL, de Farias IC, Begnami MD, Soares FA. Total gastrectomy for gastric cancer: an analysis of postoperative and long-term outcomes through time: results of 413 consecutive cases in a single cancer center. Ann Surg Oncol 2015;22:750-7. [PMID: 25366586 DOI: 10.1245/s10434-014-4212-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]